- Home
- TTNP vs ENSC Comparison
TTNP vs ENSC Comparison
Compare TTNP & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- ENSC
- Stock Information
- Founded
- TTNP 1991
- ENSC 2003
- Country
- TTNP United States
- ENSC United States
- Employees
- TTNP N/A
- ENSC N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- ENSC Health Care
- Exchange
- TTNP Nasdaq
- ENSC Nasdaq
- Market Cap
- TTNP 3.4M
- ENSC 3.4M
- IPO Year
- TTNP 1996
- ENSC N/A
- Fundamental
- Price
- TTNP $4.65
- ENSC $2.38
- Analyst Decision
- TTNP
- ENSC
- Analyst Count
- TTNP 0
- ENSC 0
- Target Price
- TTNP N/A
- ENSC N/A
- AVG Volume (30 Days)
- TTNP 81.0K
- ENSC 455.1K
- Earning Date
- TTNP 05-14-2025
- ENSC 05-13-2025
- Dividend Yield
- TTNP N/A
- ENSC N/A
- EPS Growth
- TTNP N/A
- ENSC N/A
- EPS
- TTNP N/A
- ENSC N/A
- Revenue
- TTNP N/A
- ENSC $6,224,081.00
- Revenue This Year
- TTNP N/A
- ENSC N/A
- Revenue Next Year
- TTNP N/A
- ENSC $1,381.48
- P/E Ratio
- TTNP N/A
- ENSC N/A
- Revenue Growth
- TTNP N/A
- ENSC 256.35
- 52 Week Low
- TTNP $3.03
- ENSC $1.62
- 52 Week High
- TTNP $14.80
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- TTNP 53.37
- ENSC 49.99
- Support Level
- TTNP $4.16
- ENSC $2.12
- Resistance Level
- TTNP $5.12
- ENSC $2.57
- Average True Range (ATR)
- TTNP 0.44
- ENSC 0.21
- MACD
- TTNP -0.01
- ENSC 0.04
- Stochastic Oscillator
- TTNP 51.54
- ENSC 53.87
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.